Pacific Biosciences: Looks Appealing In The Fast-Growing Long-Read Sequencing Market [Seeking Alpha]
Pacific Biosciences of California, Inc. (PACB)
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacificbiosciences.com
Company Research
Source: Seeking Alpha
Editor's note: Seeking Alpha is proud to welcome DZ Research as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Premium.Click here to find out more »ebrublue10My thesisGoals of this article are to assess the competitive landscape of Pacific Biosciences of California (NASDAQ:PACBInvestment overviewThe technological advance of PACB within long-read sequencing wasrecognized by Illumina, trying to acquire the Californian company in 2019. Since then, the product update from Sequel II to Revio has been quite impressive. However, competition cannot be understated and will be intense. Main direct competitors are Illumina, Oxford Nanopore (OTCPK:ONTTF) and Beijing Genomics Institute (BGI). Illumina launched a product in March 2023 allowing for long-read sequencing but at a cost of $1,350 per full genome: higher than the $1,200 per sequencing of Oxford Nanopo
Show less
Read more
Impact Snapshot
Event Time:
PACB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PACB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PACB alerts
High impacting Pacific Biosciences of California, Inc. news events
Weekly update
A roundup of the hottest topics
PACB
News
- Pacific Biosciences: Longer Reads, But Shorter Patience (Downgrade) [Seeking Alpha]Seeking Alpha
- Pacific Biosciences of California (NASDAQ:PACB) had its price target raised by analysts at Barclays PLC from $1.50 to $2.00. They now have an "equal weight" rating on the stock.MarketBeat
- Why PacBio (PACB) Stock Is Up Today [Yahoo! Finance]Yahoo! Finance
- PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- PacBio to Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
PACB
Earnings
- 11/5/25 - Beat
PACB
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/6/25 - Form 10-Q
- 11/5/25 - Form 8-K
- PACB's page on the SEC website